• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物掩味技术的发展趋势:专利综述

Trends in pharmaceutical taste masking technologies: a patent review.

作者信息

Ayenew Zelalem, Puri Vibha, Kumar Lokesh, Bansal Arvind K

机构信息

Department of Pharmaceutical Technology, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Punjab, India.

出版信息

Recent Pat Drug Deliv Formul. 2009 Jan;3(1):26-39. doi: 10.2174/187221109787158364.

DOI:10.2174/187221109787158364
PMID:19149727
Abstract

According to the year 2003 survey of pediatricians by the American Association of Pediatrics, unpleasant taste was the biggest barrier for completing treatment in pediatrics. The field of taste masking of active pharmaceutical ingredients (API) has been continuously evolving with varied technologies and new excipients. The article reviews the trends in taste masking technologies by studying the current state of the art patent database for the span of year 1997 to 2007. The worldwide database of European patent office (http://ep.espacenet.com) was employed to collect the patents and patent applications. It also discusses the possible reasons for the change of preferences in the taste masking technologies with time. The prime factors critical to the selection of an optimal taste masking technique such as the extent of drug bitterness, solubility, particle characteristics, dosage form and dose are briefly discussed.

摘要

根据美国儿科学会2003年对儿科医生的调查,不良味道是儿科治疗完成过程中的最大障碍。活性药物成分(API)掩味领域一直在随着各种技术和新型辅料不断发展。本文通过研究1997年至2007年期间的现有技术专利数据库,回顾了掩味技术的发展趋势。利用欧洲专利局的全球数据库(http://ep.espacenet.com)收集专利和专利申请。本文还讨论了掩味技术偏好随时间变化的可能原因。简要讨论了选择最佳掩味技术的关键主要因素,如药物苦味程度、溶解度、颗粒特性、剂型和剂量。

相似文献

1
Trends in pharmaceutical taste masking technologies: a patent review.药物掩味技术的发展趋势:专利综述
Recent Pat Drug Deliv Formul. 2009 Jan;3(1):26-39. doi: 10.2174/187221109787158364.
2
Patent landscape of pediatric-friendly oral dosage forms and administration devices.儿科口服剂型和给药装置的专利全景。
Expert Opin Ther Pat. 2021 Jul;31(7):663-686. doi: 10.1080/13543776.2021.1893691. Epub 2021 Apr 19.
3
Recent patents and patented technology platforms for pharmaceutical taste masking.近期用于药物掩味的专利及专利技术平台
Recent Pat Drug Deliv Formul. 2014 Apr;8(1):37-45. doi: 10.2174/1872211308666140206150840.
4
Orally disintegrating systems: innovations in formulation and technology.口腔崩解系统:制剂与技术的创新
Recent Pat Drug Deliv Formul. 2008;2(3):258-74. doi: 10.2174/187221108786241660.
5
Co-processed excipients: a patent review.共处理辅料:专利综述
Recent Pat Drug Deliv Formul. 2013 Apr;7(1):73-83. doi: 10.2174/187221113804805847.
6
Practical approaches of taste masking technologies in oral solid forms.口腔固体制剂中味觉掩盖技术的实用方法。
Expert Opin Drug Deliv. 2007 Jul;4(4):417-26. doi: 10.1517/17425247.4.4.417.
7
[Taste-masking possibilities in solid dosage forms].[固体剂型中的味觉掩蔽可能性]
Acta Pharm Hung. 2012;82(2):81-90.
8
Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms.通过与环糊精络合改善药物苦味:应用、评价及作用机制
Ther Deliv. 2012 May;3(5):633-44. doi: 10.4155/tde.12.28.
9
Modern pediatric formulations of the soft candies in the form of a jelly: determination of metoclopramide content and dissolution.现代儿科软糖剂型的果冻制剂:测定胃复安含量和溶出度。
Pharm Dev Technol. 2020 Jan;25(1):20-27. doi: 10.1080/10837450.2019.1609499. Epub 2019 Nov 5.
10
An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods.掩味技术概述:方法、应用和评估方法。
AAPS PharmSciTech. 2023 Feb 14;24(2):67. doi: 10.1208/s12249-023-02520-z.

引用本文的文献

1
Poor-tasting pediatric medicines: part 2. Exploring caregiver and healthcare provider values and preferences for a novel taste-blocker product to improve acceptability.口感不佳的儿科药物:第2部分。探索护理人员和医疗服务提供者对新型味觉阻滞剂产品的价值观和偏好,以提高可接受性。
Front Drug Deliv. 2025 Apr 22;5:1555522. doi: 10.3389/fddev.2025.1555522. eCollection 2025.
2
Hot Melt Extrusion Technology in Taste Masking.热熔挤出技术在掩味中的应用
AAPS PharmSciTech. 2025 Jul 22;26(7):196. doi: 10.1208/s12249-025-03174-9.
3
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features.
固体口服药物治疗中的固定剂量复方制剂:优势、局限性及设计特点
Pharmaceutics. 2024 Jan 26;16(2):178. doi: 10.3390/pharmaceutics16020178.
4
Responsive Sensory Evaluation to Develop Flexible Taste-Masked Paediatric Primaquine Tablets against Malaria for Low-Resource Settings.通过响应式感官评估开发针对资源匮乏地区疟疾的口感掩蔽型小儿伯氨喹片。
Pharmaceutics. 2023 Jul 4;15(7):1879. doi: 10.3390/pharmaceutics15071879.
5
An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods.掩味技术概述:方法、应用和评估方法。
AAPS PharmSciTech. 2023 Feb 14;24(2):67. doi: 10.1208/s12249-023-02520-z.
6
Dose of sucrose affects the efficacy of Qiweibaizhu powder on antibiotic-associated diarrhea: Association with intestinal mucosal microbiota, short-chain fatty acids, IL-17, and MUC2.蔗糖剂量影响七味白术散对抗生素相关性腹泻的疗效:与肠道黏膜微生物群、短链脂肪酸、白细胞介素-17和黏蛋白2的关联
Front Microbiol. 2023 Jan 19;14:1108398. doi: 10.3389/fmicb.2023.1108398. eCollection 2023.
7
Surface Modifiers on Composite Particles for Direct Compaction.用于直接压片的复合颗粒表面改性剂
Pharmaceutics. 2022 Oct 18;14(10):2217. doi: 10.3390/pharmaceutics14102217.
8
Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.优化的无崩解剂舒马曲坦-丙氯拉嗪复方口溶膜的研制:体外、离体和体内特性研究。
AAPS PharmSciTech. 2022 Jun 2;23(5):156. doi: 10.1208/s12249-022-02307-8.
9
In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use.基于(2-羟丙基)-β-环糊精的螺内酯水溶液制剂用于儿科的体内研究。
Pharmaceutics. 2022 Apr 3;14(4):780. doi: 10.3390/pharmaceutics14040780.
10
Continuous Melt Granulation for Taste-Masking of Ibuprofen.布洛芬掩味的连续熔融造粒法
Pharmaceutics. 2021 Jun 11;13(6):863. doi: 10.3390/pharmaceutics13060863.